Daniel Collerton

8.5k total citations · 1 hit paper
72 papers, 3.0k citations indexed

About

Daniel Collerton is a scholar working on Cognitive Neuroscience, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Daniel Collerton has authored 72 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Cognitive Neuroscience, 31 papers in Psychiatry and Mental health and 14 papers in Neurology. Recurrent topics in Daniel Collerton's work include Hallucinations in medical conditions (46 papers), Schizophrenia research and treatment (15 papers) and Parkinson's Disease Mechanisms and Treatments (13 papers). Daniel Collerton is often cited by papers focused on Hallucinations in medical conditions (46 papers), Schizophrenia research and treatment (15 papers) and Parkinson's Disease Mechanisms and Treatments (13 papers). Daniel Collerton collaborates with scholars based in United Kingdom, Switzerland and Australia. Daniel Collerton's co-authors include Ian G. McKeith, Elaine Perry, David J. Burn, Robert Dudley, John‐Paul Taylor, Urs P. Mosimann, John T. O’Brien, Rachael A. Lawson, Flavie Waters and Gordon W. Duncan and has published in prestigious journals such as Neurology, Neuroscience and Ophthalmology.

In The Last Decade

Daniel Collerton

69 papers receiving 2.9k citations

Hit Papers

Cholinergic function and intellectual decline in Alzheime... 1986 2026 1999 2012 1986 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Collerton United Kingdom 25 1.5k 1000 928 493 365 72 3.0k
Sibel Tekin United States 21 1.1k 0.7× 1.7k 1.7× 1.4k 1.5× 469 1.0× 889 2.4× 35 3.8k
Byron Creese United Kingdom 24 547 0.4× 997 1.0× 853 0.9× 226 0.5× 474 1.3× 86 2.5k
Antonella Pollo Italy 25 2.1k 1.4× 746 0.7× 286 0.3× 292 0.6× 754 2.1× 43 3.0k
Philipp A. Thomann Germany 38 1.6k 1.1× 1.6k 1.6× 603 0.6× 518 1.1× 360 1.0× 110 3.8k
J.B. Deijen Netherlands 32 1.2k 0.8× 442 0.4× 708 0.8× 341 0.7× 597 1.6× 97 3.3k
Uwe Ehrt Norway 17 559 0.4× 786 0.8× 2.0k 2.2× 476 1.0× 311 0.9× 33 3.0k
John T. Little United States 23 836 0.6× 603 0.6× 562 0.6× 364 0.7× 194 0.5× 35 2.4k
Marc‐André Bédard Canada 30 1.6k 1.1× 545 0.5× 1.0k 1.1× 530 1.1× 853 2.3× 56 3.2k
Nico J. Diederich Luxembourg 35 1.3k 0.9× 457 0.5× 2.7k 2.9× 754 1.5× 424 1.2× 88 4.0k
Márcia Radanovic Brazil 33 779 0.5× 1.6k 1.6× 254 0.3× 239 0.5× 872 2.4× 116 3.2k

Countries citing papers authored by Daniel Collerton

Since Specialization
Citations

This map shows the geographic impact of Daniel Collerton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Collerton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Collerton more than expected).

Fields of papers citing papers by Daniel Collerton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Collerton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Collerton. The network helps show where Daniel Collerton may publish in the future.

Co-authorship network of co-authors of Daniel Collerton

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Collerton. A scholar is included among the top collaborators of Daniel Collerton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Collerton. Daniel Collerton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barrett, Frederick S., Daniel Collerton, David Dupuis, et al.. (2025). Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases. Schizophrenia Bulletin. 51(Supplement_3). S273–S291.
2.
Collerton, Daniel, Ichiro Tsuda, & Shigetoshi Nara. (2024). Episodic Visual Hallucinations, Inference and Free Energy. Entropy. 26(7). 557–557.
3.
Firbank, Michael, Daniel Collerton, Julia Schumacher, et al.. (2023). Functional connectivity in Lewy body disease with visual hallucinations. European Journal of Neurology. 31(2). e16115–e16115. 8 indexed citations
4.
Dudley, Robert, Charlotte Aynsworth, Urs P. Mosimann, et al.. (2018). A comparison of visual hallucinations across disorders. Psychiatry Research. 272. 86–92. 22 indexed citations
5.
Dudley, Robert, et al.. (2018). Prevalence and characteristics of multi-modal hallucinations in people with psychosis who experience visual hallucinations. Psychiatry Research. 269. 25–30. 39 indexed citations
6.
Elder, Greg J., et al.. (2018). The utility and application of electrophysiological methods in the study of visual hallucinations. Clinical Neurophysiology. 129(11). 2361–2371. 11 indexed citations
7.
8.
Bruce, Vicki, et al.. (2017). Compensatory shifts in visual perception are associated with hallucinations in Lewy body disorders. Cognitive Research Principles and Implications. 2(1). 26–26. 8 indexed citations
9.
Aynsworth, Charlotte, Daniel Collerton, & Robert Dudley. (2017). Measures of visual hallucinations: Review and recommendations. Clinical Psychology Review. 57. 164–182. 18 indexed citations
10.
Collerton, Daniel, John‐Paul Taylor, Ichiro Tsuda, et al.. (2016). How Can We See Things That Are Not There? Current Insights into Complex Visual Hallucinations. Journal of Consciousness Studies. 12 indexed citations
11.
Waters, Flavie, Jan Dirk Blom, Thien Thanh Dang‐Vu, et al.. (2016). What Is the Link Between Hallucinations, Dreams, and Hypnagogic–Hypnopompic Experiences?. Schizophrenia Bulletin. 42(5). 1098–1109. 77 indexed citations
12.
Collerton, Daniel, et al.. (2015). Is Seeing Believing? The Process of Change During Cognitive–behavioural Therapy for Distressing Visual Hallucinations. Clinical Psychology & Psychotherapy. 23(4). 285–297. 20 indexed citations
13.
Lawson, Rachael A., Alison J. Yarnall, Gordon W. Duncan, et al.. (2015). Quality of Life and Mild Cognitive Impairment in Early Parkinson’s Disease: Does Subtype Matter?. Journal of Parkinson s Disease. 4(3). 331–336. 25 indexed citations
14.
Urwyler, Prabitha, Tobias Nef, René M. Müri, et al.. (2015). Visual Hallucinations in Eye Disease and Lewy Body Disease. American Journal of Geriatric Psychiatry. 24(5). 350–358. 21 indexed citations
15.
Killen, Alison, Michael Firbank, Daniel Collerton, et al.. (2012). The assessment of cognition in visually impaired older adults. Age and Ageing. 42(1). 98–102. 28 indexed citations
16.
Dean, Jennifer, et al.. (2010). Specific attentional impairments and complex visual hallucinations in eye disease. International Journal of Geriatric Psychiatry. 26(3). 263–267. 16 indexed citations
17.
Mosimann, Urs P., Daniel Collerton, Robert Dudley, et al.. (2008). A semi‐structured interview to assess visual hallucinations in older people. International Journal of Geriatric Psychiatry. 23(7). 712–718. 89 indexed citations
18.
McKeith, Ian G., David J. Burn, Clive Ballard, et al.. (2003). Dementia with Lewy bodies. PubMed. 8(1). 46–57. 105 indexed citations
19.
Marshall, Richard & Daniel Collerton. (2000). The resourceful provision of supervision. Clinical Psychology Forum. 1(135). 27–30.
20.
Perry, EK, Elizabeth Marshall, Paul M. Thompson, et al.. (1993). Monoaminergic activities in Lewy Body dementia: Relation to hallucinosis and extrapyramidal features. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 6(3). 167–177. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026